Hospital Alemão Oswaldo Cruz

São Paulo, São Paulo 01327-001

0 studies enrolling now · 4 studies all time

What they study most

COVID-19, Cardiovascular Risk, Chronic Kidney Disease, Heart Failure, Respiratory Syncytial Virus Infections, mCRPC

Studies at this site

• Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPC — Running, not enrolling
• Levels of Inflammation in People With Cardiovascular Disease (POSEIDON) — Completed
• Effects of EDP-938 in Hematopoietic Cell Transplant Recipients Infected With Respiratory Syncytial Virus of the Upper Respiratory Tract — Stopped early
• Evaluation of Protease Inhibition for COVID-19 in Standard-Risk Patients (EPIC-SR). — Stopped early